Charming Medical Limited cash flow statement MCTA

Annual Quarterly

In fiscal 2026, which ended Mar 31, 2026, Charming Medical Limited used $1.2 million of cash from operations. It spent $339,560 on capital expenditures. Free cash flow was negative, at -$1.6 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Mar 31, 2026
Operating
Depreciation and amortization
0
Operating cash flow
-1
Investing
Capital expenditures
0
Investing cash flow
-0
Financing
Financing cash flow
5
Change in cash
Effect of exchange rate
-0
Free cash flow
-2
Per share
Free cash flow per share
-0.10
Ratios
Free cash flow margin
-59.40%
Capital expenditures to revenue
12.97%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MCTA (Nasdaq)
Headquarters
Hong Kong, Hong Kong
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2035992

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.